The risk of contralateral breast cancer among carriers of germline pathogenic variants in BRCA1/2 with a primary diagnosis of breast cancer [1] is 62–83% higher than in women not carrying these mutations over their lifetimes [2]. This evidence concerns the gene BRCA1 and breast carcinoma.